CareLit · DOI-Nachweis · Klinische Pädiatrie
GRHL1 inhibits tumorigenicity and is a prognostic marker in neuroblastoma
DOI 10.1055/s-0033-1343646
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Fabian, M Lodrini, MC Schier, T Thole, A Kopp-Schneider, D Capper, A von Deimling, I Oehme, I Wiegand, T Milde, F Roels, M Fischer, AE Kulozik, O Witt, HE Deubzer
ZeitschriftKlinische Pädiatrie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Inhibition of histone deacetylase activity by small molecules (HDACi) favorably impacts neuroblastoma (NB) biology. Here, we aimed to decipher the underlying molecular mechanisms that have remained enigmatic via gene expression profiling of cell lines in time-course. GRHL1, a highly conserved neuroectodermal developmental transcription factor with no prior defined role in oncology, was among the five strongest immed…
Zitieren
Zitierempfehlung
J Fabian, M Lodrini, MC Schier, T Thole, A Kopp-Schneider, D Capper, A von Deimling, I Oehme, I Wiegand, T Milde, F Roels, M Fischer, AE Kulozik, O Witt, HE Deubzer (2013) GRHL1 inhibits tumorigenicity and is a prognostic marker in neuroblastoma. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0033-1343646
Mit CareLit weiterarbeiten